annual SGA:
$321.58M-$14.78M(-4.39%)Summary
- As of today (September 14, 2025), SUPN annual SGA is $321.58 million, with the most recent change of -$14.78 million (-4.39%) on December 31, 2024.
- During the last 3 years, SUPN annual SGA has risen by +$16.82 million (+5.52%).
- SUPN annual SGA is now -14.75% below its all-time high of $377.22 million, reached on December 31, 2022.
Performance
SUPN SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$0.00-$89.94M(-100.00%)Summary
- As of today (September 14, 2025), SUPN quarterly SGA is $0.00, with the most recent change of -$89.94 million (-100.00%) on June 30, 2025.
- Over the past year, SUPN quarterly SGA has dropped by -$85.90 million (-100.00%).
- SUPN quarterly SGA is now -100.00% below its all-time high of $112.31 million, reached on September 30, 2022.
Performance
SUPN quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
$2.21B+$64.50M(+3.01%)Summary
- As of today (September 14, 2025), SUPN TTM SGA is $2.21 billion, with the most recent change of +$64.50 million (+3.01%) on June 30, 2025.
- Over the past year, SUPN TTM SGA has increased by +$1.87 billion (+556.72%).
- SUPN TTM SGA is now at all-time high.
Performance
SUPN TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
SUPN Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -4.4% | -100.0% | +556.7% |
| 3 y3 years | +5.5% | -100.0% | +505.8% |
| 5 y5 years | +109.8% | -100.0% | +1220.1% |
SUPN Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -14.8% | +5.5% | -100.0% | at low | at high | +33.3% |
| 5 y | 5-year | -14.8% | +109.8% | -100.0% | at low | at high | +162.1% |
| alltime | all time | -14.8% | +7916.1% | -100.0% | at low | at high | +404.1% |
SUPN Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $0.00(-100.0%) | $159.70M(-35.0%) |
| Mar 2025 | - | $89.94M(>+9900.0%) | $245.60M(+1.4%) |
| Dec 2024 | $321.58M(-4.4%) | $0.00(-100.0%) | $242.17M(-25.1%) |
| Sep 2024 | - | $69.75M(-18.8%) | $323.45M(-3.8%) |
| Jun 2024 | - | $85.90M(-0.7%) | $336.40M(-0.3%) |
| Mar 2024 | - | $86.52M(+6.4%) | $337.28M(+0.3%) |
| Dec 2023 | $336.36M(-10.8%) | $81.28M(-1.7%) | $336.36M(+2.2%) |
| Sep 2023 | - | $82.70M(-4.7%) | $329.05M(-8.3%) |
| Jun 2023 | - | $86.78M(+1.4%) | $358.67M(-3.7%) |
| Mar 2023 | - | $85.60M(+15.7%) | $372.36M(-1.3%) |
| Dec 2022 | $377.22M(+23.8%) | $73.97M(-34.1%) | $377.22M(-6.9%) |
| Sep 2022 | - | $112.31M(+11.8%) | $404.98M(+11.0%) |
| Jun 2022 | - | $100.48M(+11.1%) | $364.70M(+9.3%) |
| Mar 2022 | - | $90.46M(-11.1%) | $333.76M(+9.5%) |
| Dec 2021 | $304.76M(+51.9%) | $101.73M(+41.2%) | $304.76M(+17.4%) |
| Sep 2021 | - | $72.03M(+3.6%) | $259.52M(+7.2%) |
| Jun 2021 | - | $69.53M(+13.1%) | $242.15M(+9.7%) |
| Mar 2021 | - | $61.46M(+8.8%) | $220.72M(+9.2%) |
| Dec 2020 | $200.68M(+31.0%) | $56.50M(+3.4%) | $202.14M(+11.5%) |
| Sep 2020 | - | $54.66M(+13.6%) | $181.36M(+8.4%) |
| Jun 2020 | - | $48.10M(+12.2%) | $167.35M(+4.4%) |
| Mar 2020 | - | $42.88M(+20.0%) | $160.33M(+1.2%) |
| Dec 2019 | $153.25M(-0.9%) | $35.73M(-12.1%) | $158.43M(-3.8%) |
| Sep 2019 | - | $40.65M(-1.1%) | $164.75M(-0.1%) |
| Jun 2019 | - | $41.08M(+0.3%) | $164.99M(+0.6%) |
| Mar 2019 | - | $40.97M(-2.6%) | $164.01M(+2.6%) |
| Dec 2018 | $154.70M(+12.2%) | $42.05M(+2.8%) | $159.89M(+5.5%) |
| Sep 2018 | - | $40.89M(+2.0%) | $151.60M(+0.0%) |
| Jun 2018 | - | $40.10M(+8.8%) | $151.53M(+3.4%) |
| Mar 2018 | - | $36.85M(+9.1%) | $146.52M(+6.2%) |
| Dec 2017 | $137.91M | $33.76M(-17.3%) | $137.91M(+3.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | $40.83M(+16.4%) | $133.20M(+12.8%) |
| Jun 2017 | - | $35.08M(+24.2%) | $118.05M(+8.2%) |
| Mar 2017 | - | $28.24M(-2.8%) | $109.09M(+2.9%) |
| Dec 2016 | $106.01M(+19.0%) | $29.05M(+13.2%) | $106.01M(+5.5%) |
| Sep 2016 | - | $25.68M(-1.7%) | $100.52M(+2.8%) |
| Jun 2016 | - | $26.12M(+3.8%) | $97.75M(+3.1%) |
| Mar 2016 | - | $25.16M(+6.8%) | $94.82M(+6.5%) |
| Dec 2015 | $89.06M(+22.7%) | $23.57M(+2.9%) | $89.06M(+6.6%) |
| Sep 2015 | - | $22.90M(-1.3%) | $83.52M(+7.1%) |
| Jun 2015 | - | $23.19M(+19.5%) | $77.96M(+4.9%) |
| Mar 2015 | - | $19.40M(+7.7%) | $74.34M(+2.6%) |
| Dec 2014 | $72.61M(+30.6%) | $18.02M(+3.9%) | $72.47M(+4.0%) |
| Sep 2014 | - | $17.34M(-11.4%) | $69.67M(+4.1%) |
| Jun 2014 | - | $19.58M(+11.7%) | $66.95M(+12.4%) |
| Mar 2014 | - | $17.53M(+15.1%) | $59.59M(+7.2%) |
| Dec 2013 | $55.59M(+176.1%) | $15.22M(+4.1%) | $55.59M(+13.3%) |
| Sep 2013 | - | $14.62M(+19.7%) | $49.05M(+27.4%) |
| Jun 2013 | - | $12.21M(-9.7%) | $38.50M(+24.5%) |
| Mar 2013 | - | $13.53M(+55.9%) | $30.93M(+53.7%) |
| Dec 2012 | $20.13M(+153.9%) | $8.68M(+113.1%) | $20.13M(+41.4%) |
| Sep 2012 | - | $4.08M(-12.3%) | $14.23M(+22.1%) |
| Jun 2012 | - | $4.64M(+70.3%) | $11.66M(+30.9%) |
| Mar 2012 | - | $2.73M(-2.0%) | $8.91M(+12.4%) |
| Dec 2011 | $7.93M(+56.1%) | $2.79M(+85.5%) | $7.93M(+16.0%) |
| Sep 2011 | - | $1.50M(-20.8%) | $6.83M(+28.1%) |
| Jun 2011 | - | $1.90M(+8.5%) | $5.33M(+55.1%) |
| Mar 2011 | - | $1.75M(+3.3%) | $3.44M(+103.3%) |
| Dec 2010 | $5.08M(+9.3%) | $1.69M(+47.6%) | $1.69M(+47.6%) |
| Dec 2009 | $4.65M(+8.4%) | $1.15M | $1.15M |
| Dec 2008 | $4.29M(+6.9%) | - | - |
| Dec 2007 | $4.01M | - | - |
FAQ
- What is Supernus Pharmaceuticals, Inc. annual SGA?
- What is the all time high annual SGA for Supernus Pharmaceuticals, Inc.?
- What is Supernus Pharmaceuticals, Inc. annual SGA year-on-year change?
- What is Supernus Pharmaceuticals, Inc. quarterly SGA?
- What is the all time high quarterly SGA for Supernus Pharmaceuticals, Inc.?
- What is Supernus Pharmaceuticals, Inc. quarterly SGA year-on-year change?
- What is Supernus Pharmaceuticals, Inc. TTM SGA?
- What is the all time high TTM SGA for Supernus Pharmaceuticals, Inc.?
- What is Supernus Pharmaceuticals, Inc. TTM SGA year-on-year change?
What is Supernus Pharmaceuticals, Inc. annual SGA?
The current annual SGA of SUPN is $321.58M
What is the all time high annual SGA for Supernus Pharmaceuticals, Inc.?
Supernus Pharmaceuticals, Inc. all-time high annual SGA is $377.22M
What is Supernus Pharmaceuticals, Inc. annual SGA year-on-year change?
Over the past year, SUPN annual SGA has changed by -$14.78M (-4.39%)
What is Supernus Pharmaceuticals, Inc. quarterly SGA?
The current quarterly SGA of SUPN is $0.00
What is the all time high quarterly SGA for Supernus Pharmaceuticals, Inc.?
Supernus Pharmaceuticals, Inc. all-time high quarterly SGA is $112.31M
What is Supernus Pharmaceuticals, Inc. quarterly SGA year-on-year change?
Over the past year, SUPN quarterly SGA has changed by -$85.90M (-100.00%)
What is Supernus Pharmaceuticals, Inc. TTM SGA?
The current TTM SGA of SUPN is $2.21B
What is the all time high TTM SGA for Supernus Pharmaceuticals, Inc.?
Supernus Pharmaceuticals, Inc. all-time high TTM SGA is $2.21B
What is Supernus Pharmaceuticals, Inc. TTM SGA year-on-year change?
Over the past year, SUPN TTM SGA has changed by +$1.87B (+556.72%)